Tag: Peter Handrinos
Skadden, Latham & Watkins steer USD1.12bn biotech sale
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
Now in its 20th year, IBLJ's flagship survey identifies the international firms that stand out for their expertise and impact on India-related mandates
Follow us on LinkedIn